期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

2011年ACCF/AHA/HRS心房颤动治疗更新解读 被引量：3

Interpretation of 2011 ACCF/AHA/HRS Focused Update on the Management of Patients with Atrial Fibrillation
下载PDF
导出
摘要 2011年ACCF/AHA临床指南工作组根据近年临床试验的结果对目前心房颤动(房颤)的治疗指南提出重点更新建议,主要有:(1)心室率控制策略的新认识:严格还是宽松;(2)房颤抗栓的新方案和新药物(达必加群);(3)决奈达隆用于房颤转复、维持窦性心律以及对经导管消融治疗房颤的新观点。作者根据对相关临床资料的回顾提出了对指南更新要点的思考和认识。 The American College of Cardiology Foundation/American Heart Association（ACCF/AHA） Task Force on Practice Guidelines delivered focus update on the management of patients with atrial fibrillation（Af） according to outcomes of new cinical trials.Recommendations are on three areas,including（1） new recommendations for heart rate control of Af： strict or lenient （2） new antithrombotic therapy and new antithrombotic agent（dabigatran）,and（3） use of dronedarone for prevention of recurrent Af and new opinion in catheter-based ablation therapy for Af.The author brings up some perspectives of these recommendations after reviewing evidence supporting current update.
作者 谭琛 崔俊玉
机构地区 北京军区总医院心肺血管中心
出处 《心血管病学进展》 CAS 2011年第3期314-317,共4页 Advances in Cardiovascular Diseases
关键词 心房颤动 治疗 解读 atrial fibrillation management interpretation
分类号 R541.75 [医药卫生—心血管疾病]
  • 相关文献

参考文献24

  • 1van Gelder IC,Groenveld HF, Crijns HJ,et al. Lenient versus strict rate control in patients with atrial fibrillation [ J ]. N Engl J Med,2010.362 : 1363-1373.
  • 2Connolly S,Pogue J ,Hart R ,et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W) : a randomised controlled trial [ J ]. Lancet, 2006,367 : 1903-1912.
  • 3Connolly SJ, Pogue J, Hart RG,ct al. Eiffect of clopidogrel added to aspirin in patients with atrial fibrillation[J]. N Engl J Med,2009,360:2066-2078.
  • 4Connolly, SJ,Ezekowitz MD, Yusuf S,et al. Dabigatran versus warfarin in patients with atrial fibrillation[ J ]. N Engl J Mecd,2009,361:1139-1151.
  • 5Patel C, Yan GX Kowey PR. Dronedarone[ J ].Circulation, 2009, 120:636- 644.
  • 6Hohnloser SH,Crijns HJ,van Eickels M. Effect of dronedarone on cardiovascular events in atrial fibrillation [ published correction appears in N Engl J Med. 2009, 360:2487] [J]. N Engl J Meal,2009,360:668-678.
  • 7Singh BN, Connolly SJ, Crijns HJ, el al. Dronedamne for maintenance of sinus rhythm in alrial fibrillation or flulter[ J ]. N Engl J Meal,2007,357:987-999.
  • 8Touboul P,Brugada J,Capueei A,et al. Dronedarone for prevention of atrial fibrillation: a dose-ranging study[ J ]. Eur Heart J ,2003,24:1481-1487.
  • 9le Heuzey JY, de Ferrari GM, Radzik D, et al. A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and szletv of drunedarone versus amiodarone in patients with persistent atrial fibrillation: Tile DIONYSOS Study[J]. J Cardiovasc Electrophysiol,2010,21:597-605.
  • 10Kober L,Torp-Pedersen C,McMunay JJ,et al. Increased mortality after dronedaronc therap) for sevcre heart failure [ J ]. N Engl J Meal,2008, 358:2678- 2687.

同被引文献13

引证文献3

二级引证文献13

心血管病学进展
2011年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部